The week of Oct. 20 is scheduled for four IPOs to begin trading in the public markets. All four companies will list on the Nasdaq, set for about $300 million to be raised.
Full IPO calendar HERE In order of largest IPO first.
(1) Based in Greenwich, CT, Fifth Street Asset Management (FSAM) scheduled a $200 million on the Nasdaq with a market capitalization of $1.2 billion at a price range midpoint of $25 for Wednesday, Oct. 22, 2014.
FSAM is a leading alternative asset manager with more than $5.6 billion of assets under management.
(2) Based in Waltham, MA, Proteon Therapeutics (PRTO) scheduled a $61 million IPO on Nasdaq with a market capitalization of $183 million at a price range midpoint of $13 for Wednesday, Oct. 22, 2014.
Targeting kidney failure, PRTO initiated the first of two Phase 3 trials for PRT-201 in radiocephalic AVFs, PRTO’s initial indication, in the third quarter of 2014 and expect to initiate the second Phase 3 trial in the first half of 2015.
(3) Based in St. Louis, MO, EndoStim (STIM) scheduled a $35 million IPO on the Nasdaq with a market capitalization of $92 million at a price range midpoint of $11 for the week of October 20, 2014.
STIM is a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.
(4) Based in Madison, WI, Anchor BanCorp Wisconsin (ABCW) scheduled a $10 million IPO on the Nasdaq with a market capitalization of $242 million at a price range midpoint of $26 for the week of October 20, 2014.
ABCW is a bank incorporated as a savings and loan holding company under the laws of the State of Delaware and headquartered in Madison, Wisconsin.
